Trump and Xi meet in Busan, seeking to ease U.S.-China trade tensions through tariff reductions and resumed agricultural purchases.
FDA updates biosimilars guidance to streamline approvals and boost competition, aiming to cut regulatory barriers and speed lower-cost options to market.
Fortive raises earnings guidance after better-than-expected Q3 results, but analysts note mixed underlying fundamentals.
Trump and Xi meet in Busan, seeking to ease U.S.-China trade tensions through tariff reductions and resumed agricultural purchases.
FDA updates biosimilars guidance to streamline approvals and boost competition, aiming to cut regulatory barriers and speed lower-cost options to market.
Fortive raises earnings guidance after better-than-expected Q3 results, but analysts note mixed underlying fundamentals.